window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Agentic AI

  • Artificial Intelligence,Clinical Development,Data Management,Digital Health,Healthcare leadership,Pharmaceuticals and therapeutics,Research & Development

    AI and medical affairs strategy set to redefine life sciences in 2026

    Artificial intelligence, shifting healthcare professional behaviour and rising pressure on [...]

    February 18, 2026
  • Artificial Intelligence,Data Management,Pharmaceuticals and therapeutics,Technology and platforms

    Gap emerges between agentic AI ambition and real-world use in pharma, report finds

    A growing gap has emerged between how life sciences and [...]

    January 13, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Technology and platforms

    Medable launches AI agent to automate trial master file workflows

    Medable has launched a new artificial intelligence-powered agent designed to [...]

    January 7, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Digital Health,Regulatory Affairs,Technology and platforms

    11th Day of Christmas: Medable predicts agentic AI will reshape clinical trials and regulation in 2026

    On the 11th Day of Christmas in Discover Pharma’s industry [...]

    December 31, 2025
  • Artificial Intelligence,Clinical Trials,Data Management

    Six geese a-laying: CluePoints’ AI predictions for 2026

    As our Christmas countdown continues, we move from reflections on [...]

    December 18, 2025
  • Artificial Intelligence,Clinical Development,Data Management,Drug Development,Events and Conferences,Research & Development,Technology and platforms

    Pistoia Alliance warns of scientific content crisis limiting accuracy of AI in life sciences R&D

    The Pistoia Alliance has reported new findings pointing to a [...]

    December 3, 2025
  • Artificial Intelligence,Clinical Trials,Data Management,Drug Development,Technology and platforms

    Agentic AI in pharma and how it could transform clinical trials

    Prasanna Rao, Chief Products and Innovation Officer at Saama, explains [...]

    October 12, 2025
  • Artificial Intelligence,Drug Development,Research & Development,Technology and platforms

    Causaly launches agentic AI platform for life sciences research and development

    Causaly has introduced a new artificial intelligence system that it [...]

    September 17, 2025
  • Artificial Intelligence,Clinical Trials,Technology and platforms

    Medable launches AI platform for clinical trials with monitoring tool CRA Agent

    Medable has launched Agent Studio, which it describes as the [...]

    September 9, 2025
  • Artificial Intelligence,Clinical Trials,Data Management,Regulatory Affairs

    Advarra launches AI engine to enhance operational efficiency in clinical trials

    Advarra has introduced Braid, an artificial intelligence (AI) engine designed [...]

    August 12, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Currax highlights peer-reviewed review supporting combination approaches in obesity treatment
    Categories: Obesity, Pharmaceuticals and therapeutics, Research & Development
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical Development, Clinical studies, Hematology, Regulatory Affairs, Research & Development
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top